The Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
CONTEXT: The pathogenesis of type 2 diabetes (T2D) is still incompletely understood. In-depth phenotyping of young individuals at risk for T2D can contribute to the understanding of this process. OBJECTIVE: The purpose of this study was to metabolically characterize women with recent gestational diabetes (GDM), an at-risk cohort for T2D. STUDY PARTICIPANTS: Participants were 147 women consecutively recruited 3 to 16 months after pregnancy: women who had GDM and women after a normoglycemic pregnancy (control subjects) in a 2:1 ratio. DESIGN: This was a monocenter cross-sectional analysis (Prediction, Prevention and Subclassification of Type 2 Diabetes Study [PPS-Diab]). METHODS: A 5-point oral glucose tolerance test with calculation of the insulin sensitivity index and disposition index (validation by euglycemic clamp and intravenous glucose tolerance test) was performed. In addition, anthropometrics, medical and family history, clinical chemistry and biomarkers, statistical modeling, and a magnetic resonance imaging/magnetic resonance spectroscopy substudy (body fat distribution and liver and muscle fat; n = 66) were obtained. RESULTS: Compared with control subjects, women after GDM had a reduced disposition index, higher levels of plasma fetuin-A, and a lower insulin sensitivity index. A low insulin sensitivity index was also the major determinant of pathological glucose tolerance after GDM. The factors most strongly predictive of low insulin sensitivity were high plasma leptin, body mass index, triglycerides, and waist circumference. Ectopic lipids showed no body mass index-independent associations with having had GDM or low insulin sensitivity in a magnetic resonance imaging substudy. CONCLUSIONS: We found that β-cell function is already impaired in women with recent GDM, a young at-risk cohort for T2D. In addition, our data suggest that fetuin-A and leptin signaling may be important early contributors to the pathogenesis of T2D, at this disease stage equally or more relevant than ectopic lipids and low-grade inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · cited 1×
“In addition, rather than the overall quantity of organ triglycerides, particularly reactive lipid species in distinct cellular compartments might actually contribute to the pathological IR (4, 31).”
BackgroundSkeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
DeFronzo, R. A., & Tripathy, D. (2009) · Diabetes Care · doi:10.2337/dc09-s302 · Cited by 2,102
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923 · cited 1×
“models of IR have been proposed (5), and low insulin”
BackgroundFetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
Pal, D., Dasgupta, S., Kundu, R., Maitra, S., Das, G., Mukhopadhyay, S., Ray, S., Majumdar, S. S., & Bhattacharya, S. (2012) · Nature Medicine · doi:10.1038/nm.2851 · Cited by 922 · cited 1×
“It is involved in inflammatory signaling via Toll-like receptor 4 and therefore might be relevant for the pathogenesis of both GDM and T2D (20).”
BackgroundTabák, A. G., Jokela, M., Akbaraly, T. N., Brunner, E. J., Kivimäki, M., & Witte, D. R. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60619-x · Cited by 898 · cited 1×
“This finding demonstrates that impaired -cell function is already present in young at-risk individuals and does not only develop after prolonged insulin resistance, as suggested, for example, by the Whitehall II study (3, 17).”
BackgroundRegulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531 · cited 1×
“Elevated triglycerides in insulin-resistant subjects, as we see it in our study, are generally interpreted as a consequence of the insulin-resistant liver overproducing very low-density lipoprotein particles (24, 25).”
BackgroundTaylor, R. (2013) · Diabetes Care · doi:10.2337/dc12-1805 · Cited by 485
Risk of development of diabetes mellitus after diagnosis of gestational diabetes
Feig, D. S., Zinman, B., Wang, X., & Hux, J. E. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080012 · Cited by 440
Cited by
Prevalence of Gestational Diabetes and Risk of Progression to Type 2 Diabetes: a Global Perspective
Zhu, Y., & Zhang, C. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0699-x · Cited by 1,260
Fugmann, M., Breier, M., Rottenkolber, M., Banning, F., Ferrari, U., Sacco, V., Grallert, H., Parhofer, K. G., Seissler, J., Clavel, T., et al. (2015) · Scientific Reports · doi:10.1038/srep13212 · Cited by 131
Self-citationPotzel, A. L., Gar, C., Banning, F., Sacco, V., Fritsche, A., Fritsche, L., Müssig, K., Dauben, L., Seissler, J., & Lechner, A. (2022) · PLOS ONE · doi:10.1371/journal.pone.0267258 · Cited by 20
Self-citationPatterns of plasma glucagon dynamics do not match metabolic phenotypes in young women
Gar, C., Rottenkolber, M., Sacco, V., Moschko, S., Banning, F., Hesse, N., Popp, D., Hübener, C., Seissler, J., & Lechner, A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-02014 · Cited by 18
“ISI and insulin release 0’ to 30’ in the oGTT were previously validated with data from ivGTT-euglycemic clamp tests in this cohort (24).”
BackgroundMethodSelf-citation
Metadata
- Authors
- Rottenkolber, M., Ferrari, U., Holland, L., Aertsen, S., Kammer, N. N., Hetterich, H., Fugmann, M., Banning, F., Weise, M., Sacco, V., Kohn, D., Freibothe, I., Hutter, S., Hasbargen, U., Lehmann, R., Grallert, H., Parhofer, K. G., Seissler, J., & Lechner, A.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-06
- Volume
- 100
- Issue
- 6
- Pages
- E910-E918
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2019388105
- Cited by
- 51
- References
- 12
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes. https://app.cochat.ai/papers/10.1210/jc.2014-3898
- The paper
- Rottenkolber, M., Ferrari, U., Holland, L., Aertsen, S., Kammer, N. N., Hetterich, H., Fugmann, M., Banning, F., Weise, M., Sacco, V., Kohn, D., Freibothe, I., Hutter, S., Hasbargen, U., Lehmann, R., Grallert, H., Parhofer, K. G., Seissler, J., & Lechner, A. (2015). The Diabetes Risk Phenotype of Young Women With Recent Gestational Diabetes. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2014-3898
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.